Research
Cannabis Industry Research and Resources on the use of cannabis for medicinal purposes
Hundreds of studies, along with anecdotal evidence, suggest that cannabis extracts may help in the treatment of a wide range of medical conditions including cancer, Alzheimer’s, epilepsy, Lyme disease, chronic pain, rheumatism, multiple sclerosis, anxiety disorders, asthma and diabetes.
FOUNDATIONAL STUDIES CONTRIBUTING TO THE DEVELOPMENT OF OUR PRODUCTS
Scholarly Articles
Access some of the most notable studies and articles available online regarding cannabis extracts’ potential medicinal benefits. This collection of research has played a foundational role in our thinking and the development of our cannabis products.
THE ENDOCANNABINOID SYSTEM 101
- “Why Does Cannabis Work for so Many Different Health Conditions?” from Green Flower Media, 2017
Medicinal Cannabis For Pain Relief
- “New Research Proves Marijuana Effectively Controls Chronic Pain”
from The National Academy of Sciences, Engineering and Medicine (NASEM) via HelloMD. August 2017 - Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
from Cannabis and Cannabinoid Research. June 2017
BRAIN CANCER
- “The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model”
from Molecular Cancer Therapeutics, 2014 - “Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells”
from The Journal of Clinical Investigation, 2009 - “Cannabinoids and gliomas.”
from The Journal of Molecular Neurobiology, 2007 - “A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme”
from British Journal of Cancer, 2006 - “Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism”
from The British Journal of Pharmacology, 2005 - “Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines”
from The Journal of Pharmacology, 2004 - “Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas”
from The Journal of Cancer Research & American Journal of Cancer, 2004 - “Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor”
from The Journal of Cancer Research & American Journal of Cancer, 2001
BREAST CANCER
- “Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation”
from Endocrinology, 2013 - “Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration”
from Toxicology Letters, 2012 - “Cannabinoids: a new hope for breast cancer therapy?”
from Cancer Treatment Reviews, 2012 - “Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancergrowth and invasion.”
from PLoS One, 2011 - “Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.”
from Breast Cancer Research & Treatment, 2011 - “Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition”
from Molecular Cancer, 2010 - “Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.”
from Molecular Cancer Therapeutics, 2007 - “Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation”
from Journal of Cancer Research, 2006 - “Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma”
from Journal of Pharmacology, 2006
LUNG CANCER
- “Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.”
from The FASEB Journal, 2012 - “Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.”
from Cancer Prevention Research, 2011 - “Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo”
from Oncogene, 2008
Mouth & Throat Cancer
-
“Cannabinoids inhibit cellular respiration of human oral cancer cells”
from Pharmacology, 2010
Uterine, Testicular, & Pancreatic Cancer
- “Cannabis and Cannabinoids”
from National Cancer Institute, 2014 - “Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes”
from Cancer Research, 2006
Prostate Cancer
- “The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications”
from Indian Journal of Urology, 2012 - “Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production”
from Prostate, 2003 - Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16INK4a/pRB pathway
from Carcinogenesis 23 (5), 721-725, 2002
Colorectal Cancer
- “Cannabinoids in intestinal inflammation and cancer”
from Pharmacological Research, 2009 - (PDF) “Turned-off Cannabinoid Receptor Turns on Colorectal Tumor Growth”
from The University of Texas MD Anderson Cancer Center, 2008 - “The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2”
from Gut, 2005
Ovarian Cancer
Blood Cancer
- “Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation”
from International Journal of Cancer, 2008 - “Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria”
from Molecular Cancer Research, 2006 - “Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease”
from Blood, 2002
Skin Cancer
- “Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors”
from Journal of Clinical Investigation, 2003
Liver Cancer
- “Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy”
from Cell Death & Differentiation, 2011
Biliary Tract Cancer
- “The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration”
from Cancer Investigations, 2010
Bladder Cancer
- “Marijuana may lower bladder cancer risk”
from American Urological Association, 2013
Overview Articles (All Cancers)
- “Cannabidiol as potential anticancer drug”
from British Journal of Clinical Pharmacology, 2013 - “Cannabinoids as therapeutic agents in cancer: current status and future implications”
from Oncotarget, 2014 - (PDF) “Cannabinoids for Cancer Treatment: Progress and Promise”
from Cancer Research, 2008 - “Inhibition of tumor angiogenesis by cannabinoids”
from The FASEB Journal, 2003
EPILEPSY
- “The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy”
via US National Library of Medicine / National Institutes of Health, 2017
Huntington’s Disease
- “Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors”
from ACS Chemical Neuroscience, 2009
Alzheimer’s Disease
- “Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice”
from Journal of Alzheimer’s Disease, 2015
Foundational Medicinal Cannabis/Cannabinoid Research
- (PDF) That which we call Indica, by any other name would smell as sweet
from Cannabinoids 9(1), 9-15, 2014 - Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
from PLoS One 9(3), e89566, 2014 - Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
from British Journal of Pharmacology, 163(7), 1344-1364, 2011 - Gut feelings about the endocannabinoid system
from Neurogastroenterology & Motility, 23 (5) 391–398, 2011 - (PDF) Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
from Biol. Pharm. Bull. 34(5), 774-778, 2011 - Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases
from Journal of Medicinal Chemistry 53(4): 1830–1842, 2010 - (PDF) “Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb”
from Cell Press, 2009 - (PDF) The endocannabinoid system in targeting inflammatory neurodegenerative diseases
from TRENDS in Pharmacological Sciences 28 (4), 180-187, 2007 - (PDF) The Endocannabinoid System as an Emerging Target of Pharmacotherapy
from Pharmacological Reviews 58(3), 389-462, 2006 - (PDF) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
from Nature 434, 782-786, 2005 - An Overview of the Endogenous Cannabinoid System: Components and Possible Roles of this Recently Discovered Regulatory System
from Erowid.org, v1.1 May 2003, v1.2 Feb 2005 - Letters to Nature: Leptin-regulated endocannabinoids are involved in maintaining food intake
from Nature 410, 822-825, 2001
Constance LifeSciences Corp. / Constance Pure Botanical Extracts is a Section 215 Compliant collective located in the San Francisco Bay Area, California. Copyright © 2021
DISCLAIMER: These statements have not been evaluated by the United States Food and Drug Administration. The U.S. federal government (including the FDA) maintains that cannabis is a Schedule 1 drug under the federal Controlled Substances Act, with no accepted medical use, despite the mounting evidence from the international medical community. As a result, our products cannot go through FDA testing that would enable us to make health claims, and we are required to state that Constance LifeSciences Corp. & Constance Pure Botanical Extracts products are not intended to diagnose, treat, cure, or prevent any disease, illness or medical condition. Constance LifeSciences Corp. & Constance Pure Botanical Extracts makes no healing, curative or medical claims or warranties regarding its products. If you have a medical condition or illness, please consult your physician.